Search Results

Biotech Beach

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.

June 20, 2024

·

6 min read

Biotech Beach

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

ClearPoint Neuro, Inc. announces full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System at the 2024 Biennial Meeting of the American Society of Stereotactic and Functional Neurosurgery from Saturday, June 1st – Tuesday, June 4th in Nashville.

June 1, 2024

·

5 min read

Press Releases

ClearPoint Neuro Reports Third Quarter 2024 Results

November 8, 2024

·

13 min read

Press Releases

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

October 31, 2024

·

4 min read

FDA

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

ClearPoint Neuro, Inc. today announced it has received 510(k) clearance for its Prism Bone Anchor Accessory.

April 29, 2024

·

4 min read

Business

ClearPoint Neuro Reports First Quarter 2024 Results

ClearPoint Neuro, Inc., a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced financial results for its first quarter ended March 31, 2024.

May 7, 2024

·

12 min read

Business

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

October 17, 2024

·

4 min read

Press Releases

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

November 14, 2024

·

7 min read

Biotech Beach

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.

January 24, 2024

·

4 min read

Business

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2024 first quarter on Tuesday, May 7th, after the market close.

April 23, 2024

·

4 min read